VenatoRx Pharmaceuticals to Present at the 2018 UBS Global Healthcare Conference

09:00 EDT 17 May 2018 | Businesswire

This article has expired, however you can still download the PDF.
VenatoRx Pharmaceuticals announced that its President and CEO, Christopher J. Burns, Ph.D., will present at the UBS Global Healthcare Conference on Monday, May 21, 2018 at 8:00am ET in Ballroom V at the Grand Hyatt New Yo...

Other Sources for this Article

VenatoRx Pharmaceuticals, Inc.
Heather Hunter, 610-644-8935
Vice President, Communications


More From BioPortfolio on "VenatoRx Pharmaceuticals to Present at the 2018 UBS Global Healthcare Conference"

Quick Search


Relevant Topics

MRSA (methicillin-resistant Staphylococcus aureus)
MRSA (methicillin-resistant Staphylococcus aureus) is a family of bacteria with resistance to one or more major antibiotics. There are currently 17 different strains of MRSA. Two particular strains, EMRSA15 and EMRSA16  account for 96% of MRSA blood...

Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...